Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 February 2022 | Story Anthony Mthembu | Photo Charl Devenish
Dr Munita Dunn-Coetzee
“I would like for students to walk in here and feel comfortable; it doesn’t matter what you identify as – there is a space for you here,” says Dr Munita Dunn-Coetzee, the new Director of Student Counselling and Development.

Dr Munita Dunn-Coetzee has joined the University of the Free State as the new Director of Student Counselling and Development. This is after an eleven-year stay at Stellenbosch University as the Deputy Director of the Centre for Student Structures and Communities, and later as the Director of the Centre for Student Counselling and Development.

Dr Dunn-Coetzee’s role at the UFS

As leader of the department, Dr Dunn-Coetzee sees her role as one in which she is responsible for moving her team forward. “My role is to really look at what the team needs. This is from infrastructure right through to their own personal development, and to making sure that they have what they need to get their jobs done,” she stated. In addition, Dr Dunn-Coetzee’s responsibilities include, “looking at our strategic intent, aligning with what the university wants, being relevant in terms of our service delivery, and connecting enough with the students”. In fact, one of the things she is excited about is learning from the students at the University of the Free State. “The big thing for me is to make contact with students and to engage with them about what is going on at ground level; the one thing I don’t want to be is someone who sits in the office, sends emails, and think I know what’s going on,” she explained.

A commitment to the mental health of UFS students

Although her two predecessors were internal appointments, Dr Dunn-Coetzee argues that being an external appointment allows her to have a fresh perspective. As such, one of her main priorities for the year is looking at student leaders, day residences, residences on campus, and residential heads, and analysing whether they are empowered enough to have conversations about mental-health issues with students. “The one thing that concerns me is that we have been online for two years, and now that we are telling students to come back to campus, it might evoke a level of anxiety in some students,” she explained. Therefore, ensuring that the department is student-centred in everything it does is very important to Dr Dunn-Coetzee. This varies from the way in which students are dealt with, how emails are responded to, and how students are treated when they walk into the Kovsie Health Building.

A long-term vision for the department and the university

Even though she has not been at the University of the Free State for very long, Dr Dunn-Coetzee has some long-term goals that are bound to positively impact both the students and the staff in her department. “I would like to have a research focus within our department; it is very easy to say that we are doing good work and that we have an impact on our students, but we need to have something that proves it,” she said. Therefore, an evidence-based approach is one of the directions she would like to pursue in her department. In addition, Dr Dunn-Coetzee argues that there is a need for a space in which intern psychologists can be trained. “It keeps your current staff on their toes, and it helps you to really play a role in developing psychologists in South Africa,” she expressed. Therefore, opening this space for young psychologists is something she hopes to make a reality in her time at the university. Furthermore, developing her staff and ensuring that they grow their skill set is an important goal she would like to achieve. “My focus is not to have people work here for thirty years; I need to empower them so that they can develop as much as they can. Of course, I love having them here, but in the event that they want to work somewhere else I need to make sure that they are skilled,” she said. Lastly, a goal she is adamant to achieve is to ensure that the service delivery by Student Counselling and Development is of a high standard on all three campuses.

As such, Dr Dunn-Coetzee would like to be viewed by the student community as accessible and approachable. “I would like for students to walk in here and feel comfortable; it doesn’t matter what you identify as – there is a space for you here,” she said.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept